MedTrace Logo

Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)

NCT03257436 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 586

Last updated 2022-01-03

Study results available
· View outcomes & findings →

Summary

Prospective, multi-center, single arm, post approval study to be conducted in the United States.

Conditions

  • Left Ventricular Dysfunction

Interventions

DEVICE

CRT-D

Left Ventricular MultiSite Pacing

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Saba Samir · University of Pittsburgh Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-05
Primary Completion
2020-11-19
Completion
2020-11-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257436 on ClinicalTrials.gov